OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cellular therapies for the treatment and prevention of SARS-CoV-2 infection
Susan R. Conway, Michael D. Keller, Catherine M. Bollard
Blood (2022) Vol. 140, Iss. 3, pp. 208-221
Open Access | Times Cited: 13
Susan R. Conway, Michael D. Keller, Catherine M. Bollard
Blood (2022) Vol. 140, Iss. 3, pp. 208-221
Open Access | Times Cited: 13
Showing 13 citing articles:
Next-generation treatments: Immunotherapy and advanced therapies for COVID-19
Jenny Andrea Arévalo-Romero, Sandra M. Chingaté-López, Bernardo Camacho, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26423-e26423
Open Access | Times Cited: 9
Jenny Andrea Arévalo-Romero, Sandra M. Chingaté-López, Bernardo Camacho, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26423-e26423
Open Access | Times Cited: 9
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
Yash Gupta, Oleksandr V. Savytskyi, Matt Coban, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101151-101151
Open Access | Times Cited: 30
Yash Gupta, Oleksandr V. Savytskyi, Matt Coban, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101151-101151
Open Access | Times Cited: 30
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches
Sareh Kakavandi, Bahareh Hajikhani, Paniz Azizi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Sareh Kakavandi, Bahareh Hajikhani, Paniz Azizi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Applications of virus-specific T cell therapies post-BMT
Cecilia M. Motta, Michael D. Keller, Catherine M. Bollard
Seminars in Hematology (2022) Vol. 60, Iss. 1, pp. 10-19
Closed Access | Times Cited: 17
Cecilia M. Motta, Michael D. Keller, Catherine M. Bollard
Seminars in Hematology (2022) Vol. 60, Iss. 1, pp. 10-19
Closed Access | Times Cited: 17
Predictors of impaired antibody response after SARS‐CoV ‐2 mRNA vaccination in hematopoietic cell transplant recipients: A Japanese multicenter observational study
Yasuo Mori, Naoyuki Uchida, Takuya Harada, et al.
American Journal of Hematology (2022) Vol. 98, Iss. 1, pp. 102-111
Open Access | Times Cited: 12
Yasuo Mori, Naoyuki Uchida, Takuya Harada, et al.
American Journal of Hematology (2022) Vol. 98, Iss. 1, pp. 102-111
Open Access | Times Cited: 12
The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses
Mithil Soni, Edoardo Migliori, Jianing Fu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Mithil Soni, Edoardo Migliori, Jianing Fu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Targeting SARS‐CoV ‐2 infection through CAR‐T ‐like bispecific T cell engagers incorporating ACE2
Mikail Dogan, Lina Kozhaya, Lindsey Placek, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 10
Open Access | Times Cited: 9
Mikail Dogan, Lina Kozhaya, Lindsey Placek, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 10
Open Access | Times Cited: 9
Effective virus-specific T-cell therapy for high-risk SARS-CoV-2 infections in hematopoietic stem cell transplant recipients: initial case studies and literature review
László Gopcsa, Marienn Réti, Hajnalka Andrikovics, et al.
GeroScience (2023) Vol. 46, Iss. 1, pp. 1083-1106
Open Access | Times Cited: 4
László Gopcsa, Marienn Réti, Hajnalka Andrikovics, et al.
GeroScience (2023) Vol. 46, Iss. 1, pp. 1083-1106
Open Access | Times Cited: 4
SARS-CoV-2 Specific Antibody Response and T Cell-Immunity in Immunocompromised Patients up to Six Months Post COVID: A Pilot Study
Johanna Sjöwall, Maria Hjorth, Annette Gustafsson, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 12, pp. 3535-3535
Open Access | Times Cited: 4
Johanna Sjöwall, Maria Hjorth, Annette Gustafsson, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 12, pp. 3535-3535
Open Access | Times Cited: 4
The prospect of universal coronavirus immunity: a characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses
Mithil Soni, Edoardo Migliori, Jianing Fu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Mithil Soni, Edoardo Migliori, Jianing Fu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
SOHO State of the Art Updates and Next Questions | CTLs for Infections Following Stem Cell Transplantation
Ariel Rischall, Amanda Olson
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 6, pp. 340-347
Closed Access
Ariel Rischall, Amanda Olson
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 6, pp. 340-347
Closed Access
Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities
Zuzana Nová, Tomáš Zemánek, Norbert Botek
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15122-15122
Open Access | Times Cited: 1
Zuzana Nová, Tomáš Zemánek, Norbert Botek
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15122-15122
Open Access | Times Cited: 1
Terrific cells for SARS-CoV-2
Stephen Gottschalk
Haematologica (2022) Vol. 108, Iss. 7, pp. 1724-1725
Open Access
Stephen Gottschalk
Haematologica (2022) Vol. 108, Iss. 7, pp. 1724-1725
Open Access
